annual CFI:
-$262.72M-$165.81M(-171.10%)Summary
- As of today (June 22, 2025), HALO annual cash flow from investing activities is -$262.72 million, with the most recent change of -$165.81 million (-171.10%) on December 31, 2024.
- During the last 3 years, HALO annual CFI has risen by +$143.57 million (+35.34%).
- HALO annual CFI is now -435.30% below its all-time high of $78.35 million, reached on December 31, 2020.
Performance
HALO Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$90.42M-$119.90M(-406.72%)Summary
- As of today (June 22, 2025), HALO quarterly cash flow from investing activities is -$90.42 million, with the most recent change of -$119.90 million (-406.72%) on March 31, 2025.
- Over the past year, HALO quarterly CFI has dropped by -$7.74 million (-9.36%).
- HALO quarterly CFI is now -254.72% below its all-time high of $58.44 million, reached on December 31, 2020.
Performance
HALO quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$270.46M-$7.74M(-2.95%)Summary
- As of today (June 22, 2025), HALO TTM cash flow from investing activities is -$270.46 million, with the most recent change of -$7.74 million (-2.95%) on March 31, 2025.
- Over the past year, HALO TTM CFI has dropped by -$151.04 million (-126.47%).
- HALO TTM CFI is now -311.17% below its all-time high of $128.08 million, reached on September 30, 2019.
Performance
HALO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
HALO Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -171.1% | -9.4% | -126.5% |
3 y3 years | +35.3% | -83.4% | +34.1% |
5 y5 years | -4634.6% | -337.3% | -7318.1% |
HALO Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -171.1% | +46.0% | -264.4% | +79.2% | -3314.1% | +66.2% |
5 y | 5-year | -435.3% | +46.0% | -254.7% | +79.2% | -445.2% | +66.2% |
alltime | all time | -435.3% | +46.0% | -254.7% | +79.2% | -311.2% | +66.2% |
HALO Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$90.42M(-406.7%) | -$270.46M(+2.9%) |
Dec 2024 | -$262.72M(+171.1%) | $29.48M(-117.6%) | -$262.72M(-12.6%) |
Sep 2024 | - | -$167.48M(+298.4%) | -$300.49M(+38.8%) |
Jun 2024 | - | -$42.04M(-49.2%) | -$216.46M(+81.2%) |
Mar 2024 | - | -$82.68M(+897.2%) | -$119.43M(+23.2%) |
Dec 2023 | -$96.91M(-80.1%) | -$8.29M(-90.1%) | -$96.91M(+7.2%) |
Sep 2023 | - | -$83.45M(-251.7%) | -$90.36M(+1040.7%) |
Jun 2023 | - | $54.99M(-191.4%) | -$7.92M(-98.4%) |
Mar 2023 | - | -$60.16M(+3345.7%) | -$497.86M(+2.2%) |
Dec 2022 | -$487.00M(+19.9%) | -$1.75M(+73.2%) | -$487.00M(-37.9%) |
Sep 2022 | - | -$1.01M(-99.8%) | -$784.73M(-2.0%) |
Jun 2022 | - | -$434.95M(+782.2%) | -$800.67M(+95.1%) |
Mar 2022 | - | -$49.30M(-83.5%) | -$410.34M(+1.0%) |
Dec 2021 | -$406.29M(-618.5%) | -$299.47M(+1666.4%) | -$406.29M(+739.8%) |
Sep 2021 | - | -$16.95M(-62.0%) | -$48.38M(-21.4%) |
Jun 2021 | - | -$44.62M(-1.4%) | -$61.52M(+1129.2%) |
Mar 2021 | - | -$45.25M(-177.4%) | -$5.00M(-106.4%) |
Dec 2020 | $78.35M(-1512.0%) | $58.44M(-294.2%) | $78.35M(-176.1%) |
Sep 2020 | - | -$30.09M(-352.9%) | -$102.91M(+223.5%) |
Jun 2020 | - | $11.90M(-68.8%) | -$31.81M(-949.0%) |
Mar 2020 | - | $38.11M(-131.0%) | $3.75M(-167.5%) |
Dec 2019 | -$5.55M(-322.6%) | -$122.82M(-399.6%) | -$5.55M(-104.3%) |
Sep 2019 | - | $41.00M(-13.6%) | $128.08M(+4.8%) |
Jun 2019 | - | $47.46M(+64.7%) | $122.27M(+81.9%) |
Mar 2019 | - | $28.81M(+166.6%) | $67.21M(+2595.8%) |
Dec 2018 | $2.49M(-101.5%) | $10.81M(-69.3%) | $2.49M(-101.6%) |
Sep 2018 | - | $35.19M(-562.6%) | -$157.30M(-3.0%) |
Jun 2018 | - | -$7.61M(-78.8%) | -$162.21M(-20.4%) |
Mar 2018 | - | -$35.90M(-75.9%) | -$203.90M(+24.5%) |
Dec 2017 | -$163.73M(+113.3%) | -$148.99M(-592.0%) | -$163.73M(-2698.5%) |
Sep 2017 | - | $30.28M(-161.4%) | $6.30M(-140.0%) |
Jun 2017 | - | -$49.29M(-1255.7%) | -$15.74M(-147.5%) |
Mar 2017 | - | $4.26M(-79.7%) | $33.12M(-143.1%) |
Dec 2016 | -$76.77M(-1403.8%) | $21.05M(+155.2%) | -$76.77M(-31.8%) |
Sep 2016 | - | $8.25M(-1995.6%) | -$112.57M(+12.0%) |
Jun 2016 | - | -$435.00K(-99.6%) | -$100.52M(+12.5%) |
Mar 2016 | - | -$105.62M(+615.8%) | -$89.31M(-1616.9%) |
Dec 2015 | $5.89M(-117.9%) | -$14.76M(-172.7%) | $5.89M(-82.7%) |
Sep 2015 | - | $20.29M(+88.4%) | $34.13M(+107.3%) |
Jun 2015 | - | $10.77M(-203.4%) | $16.46M(-9245.0%) |
Mar 2015 | - | -$10.42M(-177.3%) | -$180.00K(-99.5%) |
Dec 2014 | -$32.95M(-31.2%) | $13.48M(+413.0%) | -$32.95M(-25.8%) |
Sep 2014 | - | $2.63M(-144.8%) | -$44.42M(-6.2%) |
Jun 2014 | - | -$5.87M(-86.4%) | -$47.37M(+13.9%) |
Mar 2014 | - | -$43.19M(-2241.3%) | -$41.58M(-13.1%) |
Dec 2013 | -$47.87M | $2.02M(-720.6%) | -$47.87M(-5.1%) |
Sep 2013 | - | -$325.00K(+306.3%) | -$50.43M(+0.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2013 | - | -$80.00K(-99.8%) | -$50.27M(-1.3%) |
Mar 2013 | - | -$49.48M(+9066.5%) | -$50.91M(+3503.0%) |
Dec 2012 | -$1.41M(+70.5%) | -$539.80K(+222.3%) | -$1.41M(-1.2%) |
Sep 2012 | - | -$167.50K(-76.8%) | -$1.43M(+9.9%) |
Jun 2012 | - | -$721.50K(-4666.5%) | -$1.30M(+113.5%) |
Mar 2012 | - | $15.80K(-102.8%) | -$609.70K(-26.4%) |
Dec 2011 | -$828.50K(+28.2%) | -$557.00K(+1328.2%) | -$828.50K(+37.6%) |
Sep 2011 | - | -$39.00K(+32.2%) | -$602.20K(-3.5%) |
Jun 2011 | - | -$29.50K(-85.5%) | -$623.80K(-10.9%) |
Mar 2011 | - | -$203.00K(-38.6%) | -$700.40K(+8.4%) |
Dec 2010 | -$646.50K(-55.7%) | -$330.70K(+445.7%) | -$646.40K(-26.5%) |
Sep 2010 | - | -$60.60K(-42.9%) | -$879.10K(-9.3%) |
Jun 2010 | - | -$106.10K(-28.8%) | -$969.40K(-24.9%) |
Mar 2010 | - | -$149.00K(-73.6%) | -$1.29M(-11.6%) |
Dec 2009 | -$1.46M(+26.0%) | -$563.40K(+273.4%) | -$1.46M(+27.0%) |
Sep 2009 | - | -$150.90K(-64.7%) | -$1.15M(-19.8%) |
Jun 2009 | - | -$427.80K(+34.1%) | -$1.43M(+12.6%) |
Mar 2009 | - | -$319.00K(+26.4%) | -$1.27M(+9.8%) |
Dec 2008 | -$1.16M(-51.0%) | -$252.40K(-42.0%) | -$1.16M(-40.2%) |
Sep 2008 | - | -$435.40K(+63.1%) | -$1.94M(-0.1%) |
Jun 2008 | - | -$267.00K(+30.2%) | -$1.94M(-19.4%) |
Mar 2008 | - | -$205.00K(-80.2%) | -$2.41M(+1.9%) |
Dec 2007 | -$2.37M(+548.4%) | -$1.03M(+136.6%) | -$2.37M(+64.1%) |
Sep 2007 | - | -$436.70K(-40.5%) | -$1.44M(+24.2%) |
Jun 2007 | - | -$734.50K(+356.5%) | -$1.16M(+138.5%) |
Mar 2007 | - | -$160.90K(+47.2%) | -$486.80K(+33.4%) |
Dec 2006 | -$364.80K(+4.0%) | -$109.30K(-30.0%) | -$364.80K(+38.8%) |
Sep 2006 | - | -$156.20K(+158.6%) | -$262.90K(+29.3%) |
Jun 2006 | - | -$60.40K(+55.3%) | -$203.40K(-21.5%) |
Mar 2006 | - | -$38.90K(+425.7%) | -$259.10K(-26.2%) |
Dec 2005 | -$350.90K(+53.9%) | -$7400.00(-92.3%) | -$350.90K(-23.6%) |
Sep 2005 | - | -$96.70K(-16.7%) | -$459.00K(+18.9%) |
Jun 2005 | - | -$116.10K(-11.2%) | -$386.20K(+22.0%) |
Mar 2005 | - | -$130.70K(+13.2%) | -$316.60K(+38.9%) |
Dec 2004 | -$228.00K(<-9900.0%) | -$115.50K(+383.3%) | -$227.90K(+328.4%) |
Sep 2004 | - | -$23.90K(-48.6%) | -$53.20K(+21.2%) |
Jun 2004 | - | -$46.50K(+10.7%) | -$43.90K(+4.5%) |
Mar 2004 | - | -$42.00K(-170.9%) | -$42.00K(<-9900.0%) |
Dec 2003 | $0.00(0.0%) | $59.20K(-505.5%) | $0.00(-100.0%) |
Sep 2003 | - | -$14.60K(-67.3%) | -$34.20K(+74.5%) |
Jun 2003 | - | -$44.60K(<-9900.0%) | -$19.60K(<-9900.0%) |
Mar 2003 | - | $0.00(-100.0%) | $0.00(0.0%) |
Dec 2002 | $0.00(0.0%) | $25.00K(>+9900.0%) | $0.00(-100.0%) |
Sep 2002 | - | $0.00(-100.0%) | -$25.00K(0.0%) |
Jun 2002 | - | -$25.00K(<-9900.0%) | -$25.00K(<-9900.0%) |
Mar 2002 | - | $0.00 | $0.00 |
Dec 2001 | $0.00 | - | - |
FAQ
- What is Halozyme Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual CFI year-on-year change?
- What is Halozyme Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly CFI year-on-year change?
- What is Halozyme Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM CFI year-on-year change?
What is Halozyme Therapeutics annual cash flow from investing activities?
The current annual CFI of HALO is -$262.72M
What is the all time high annual CFI for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual cash flow from investing activities is $78.35M
What is Halozyme Therapeutics annual CFI year-on-year change?
Over the past year, HALO annual cash flow from investing activities has changed by -$165.81M (-171.10%)
What is Halozyme Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of HALO is -$90.42M
What is the all time high quarterly CFI for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly cash flow from investing activities is $58.44M
What is Halozyme Therapeutics quarterly CFI year-on-year change?
Over the past year, HALO quarterly cash flow from investing activities has changed by -$7.74M (-9.36%)
What is Halozyme Therapeutics TTM cash flow from investing activities?
The current TTM CFI of HALO is -$270.46M
What is the all time high TTM CFI for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM cash flow from investing activities is $128.08M
What is Halozyme Therapeutics TTM CFI year-on-year change?
Over the past year, HALO TTM cash flow from investing activities has changed by -$151.04M (-126.47%)